US Stock MarketDetailed Quotes

NOVONESIS (NOVOZYMES) B (NVZMF)

Watchlist
  • 66.326
  • +0.427+0.65%
15min DelayClose Sep 18 12:23 ET
30.92BMarket Cap42.49P/E (TTM)

NOVONESIS (NOVOZYMES) B (NVZMF) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: EUR
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/Q4
2021/Q3
Total Revenue as Reported
+9.59%1.12B
+3.87%1.12B
+1.55%996.60M
+4.36%1.06B
+4.12%1.02B
+26.26%1.08B
+58.58%981.40M
+71.15%1.02B
+72.75%978.20M
+37.53%853.50M
+2.39%618.88M
+1.53%596.22M
-1.70%566.26M
+5.60%620.60M
+17.37%604.44M
+16.09%587.24M
+19.66%576.06M
+15.76%587.68M
+11.00%515.00M
+9.79%505.87M
Total Operating Revenue
+9.59%1.12B
+3.87%1.12B
+1.55%996.60M
+4.36%1.06B
+4.12%1.02B
+26.26%1.08B
+58.58%981.40M
+71.15%1.02B
+72.75%978.20M
+37.53%853.50M
+2.39%618.88M
+1.53%596.22M
-1.70%566.26M
+5.60%620.60M
+17.37%604.44M
+16.09%587.24M
+19.66%576.06M
+15.76%587.68M
+11.00%515.00M
+9.79%505.87M
Cost of Revenue
+4.32%494.50M
+0.27%484.60M
-10.01%437.80M
+10.19%521.00M
-17.84%474.00M
-0.92%483.30M
+70.80%486.50M
+71.70%472.80M
+128.40%576.90M
+71.40%487.80M
+1.32%284.84M
+1.42%275.36M
-1.45%252.58M
+8.88%284.59M
+24.20%281.12M
+27.43%271.50M
+28.87%256.31M
+23.04%261.37M
+9.52%226.35M
+5.34%213.05M
Gross Profit
+14.18%621.70M
+6.80%634.70M
+12.91%558.80M
-0.68%543.90M
+35.68%544.50M
+62.51%594.30M
+48.15%494.90M
+70.67%547.60M
+27.93%401.30M
+8.84%365.70M
+3.32%334.04M
+1.62%320.86M
-1.90%313.68M
+2.97%336.01M
+12.01%323.33M
+7.83%315.74M
+13.17%319.75M
+10.52%326.31M
+12.18%288.65M
+13.26%292.82M
Operating Expense
+10.90%360.10M
+13.43%361.40M
+21.29%370.90M
+14.44%344.70M
+11.16%324.70M
+26.73%318.60M
+71.35%305.80M
+85.43%301.20M
+64.17%292.10M
+43.73%251.40M
-14.65%178.47M
+17.28%162.43M
+4.32%177.92M
+1.24%174.92M
+6.16%209.10M
-4.83%138.51M
+14.16%170.56M
+19.09%172.77M
+26.47%196.96M
+5.11%145.53M
Selling and Admin Expenses
+11.08%244.60M
+15.36%244.90M
+18.90%249.70M
+17.14%229.60M
+14.69%220.20M
+26.75%212.30M
+85.72%210.00M
+90.99%196.00M
+73.31%192.00M
+40.20%167.50M
+1.59%113.07M
-4.00%102.63M
+4.33%110.78M
+10.52%119.48M
-4.77%111.31M
+20.98%106.91M
+25.13%106.18M
+26.21%108.10M
+47.66%116.89M
+17.08%88.37M
-Selling & Marketing Expense
+10.94%182.60M
+20.26%185.20M
+26.89%194.40M
+27.71%175.60M
+19.19%164.60M
+26.13%154.00M
+89.95%153.20M
+93.53%137.50M
+73.14%138.10M
+42.34%122.10M
+2.07%80.65M
-2.52%71.05M
+7.51%79.76M
+9.06%85.78M
-3.43%79.01M
+18.83%72.88M
+27.71%74.19M
+33.25%78.65M
+54.25%81.82M
+19.24%61.33M
-General & Admin Expense
+11.51%62.00M
+2.40%59.70M
-2.64%55.30M
-7.69%54.00M
+3.15%55.60M
+28.41%58.30M
+75.18%56.80M
+85.26%58.50M
+73.77%53.90M
+34.74%45.40M
+0.40%32.42M
-7.19%31.58M
-3.03%31.02M
+14.43%33.69M
-7.91%32.29M
+25.84%34.02M
+19.53%31.99M
+10.60%29.44M
+34.27%35.07M
+12.46%27.04M
Research & Development
+9.40%119.90M
+12.67%120.90M
+15.79%128.30M
+9.92%118.60M
+6.51%109.60M
+17.14%107.30M
+57.35%110.80M
+74.93%107.90M
+48.80%102.90M
+31.98%91.60M
-1.40%70.42M
-3.43%61.68M
+3.32%69.15M
+4.71%69.40M
+3.85%71.42M
+9.17%63.87M
-0.25%66.93M
-12.44%66.28M
-3.60%68.77M
-8.67%58.51M
Operating Profit
+19.02%261.60M
-0.87%273.30M
-0.63%187.90M
-19.16%199.20M
+101.28%219.80M
+141.21%275.70M
+21.55%189.10M
+55.54%246.40M
-19.56%109.20M
-29.05%114.30M
+36.21%155.58M
-10.62%158.42M
-9.00%135.76M
+4.92%161.09M
+24.58%114.22M
+20.34%177.24M
+12.06%149.19M
+2.24%153.54M
-9.73%91.69M
+22.67%147.28M
Net Non-Operating Interest Income (Expense)
-90.45%-29.90M
+55.44%-8.60M
+46.96%-9.60M
+20.63%-15.00M
+35.92%-15.70M
-2.12%-19.30M
-491.16%-18.10M
-207.01%-18.90M
-257.75%-24.50M
-165.64%-18.90M
+94.00%-3.06M
-32.65%17.66M
-342.63%-6.85M
-178.51%-7.11M
-5350.17%-51.05M
+749.85%26.22M
+169.96%2.82M
+48.65%-2.55M
+50.37%-936.70K
-20.18%-4.04M
Non-Operating Interest Income
----
----
----
----
----
----
----
----
----
----
----
--1.47M
----
----
----
----
----
----
----
----
Non-Operating Interest Expense
----
----
----
----
----
----
----
----
----
----
----
----
+245.14%5.10M
----
--9.52M
--1.34M
--1.48M
----
----
----
Total Other Finance Costs
----
----
----
----
----
----
----
----
----
----
----
+41.27%-16.19M
+140.59%1.75M
+199.53%3.62M
+810.18%43.95M
-1075.96%-27.57M
-277.68%-4.30M
-66.67%1.21M
-4619.68%-6.19M
+110.32%2.82M
Special Income (Charges)
+67.77%-8.80M
+36.27%-6.50M
+75.68%-15.30M
-98.48%-13.10M
+33.25%-27.30M
+78.57%-10.20M
-131.90%-62.90M
+69.55%-6.60M
-108.62%-40.90M
-437.25%-47.60M
-152.21%-27.12M
-419.97%-21.68M
---19.61M
---8.86M
--51.95M
---4.17M
--0.00
--0.00
----
----
-Less:Restructuring and Mergern & Acquisition
-67.29%8.80M
-36.27%6.50M
-58.12%14.70M
+271.43%13.00M
-2.89%26.90M
-78.57%10.20M
-21.65%35.10M
--3.50M
--27.70M
--47.60M
--44.80M
----
----
----
----
----
----
----
----
----
-Less:Impairment of Capital Assets
-100.00%0.00
----
-78.57%600.00K
-75.00%100.00K
--400.00K
----
--2.80M
--400.00K
----
----
--0.00
----
----
----
----
----
----
----
----
----
-Less:Other Special Charges
----
----
----
----
-96.97%400.00K
----
-32.50%2.70M
--2.70M
--13.20M
----
--4.00M
----
----
--8.86M
----
----
----
----
----
----
-Less:Write Off
----
----
----
----
----
----
--22.30M
----
----
----
--0.00
----
----
----
----
----
----
----
----
----
Pretax Profit
+26.99%221.60M
+4.99%256.90M
+41.65%152.70M
-21.80%171.50M
+305.81%174.50M
+420.64%244.70M
-13.27%107.80M
+42.77%219.30M
-59.87%43.00M
-66.34%47.00M
-10.79%124.30M
-17.70%153.60M
-23.85%107.16M
-3.50%139.61M
+34.60%139.33M
+31.66%186.65M
+5.38%140.72M
-2.71%144.67M
-4.63%103.52M
+18.88%141.77M
Tax
+32.36%49.90M
-1.53%57.80M
+38.43%29.90M
-47.33%33.50M
+204.03%37.70M
+328.47%58.70M
-29.64%21.60M
+117.05%63.60M
-49.81%12.40M
-57.30%13.70M
+37.26%30.70M
-7.27%29.30M
-20.07%24.71M
+0.69%32.08M
+12.55%22.36M
+11.35%31.60M
+15.52%30.91M
+7.24%31.86M
-2.94%19.87M
+19.39%28.38M
Net Profit
+25.51%171.70M
+7.04%199.10M
+42.46%122.80M
-11.37%138.00M
+347.06%136.80M
+458.56%186.00M
-7.90%86.20M
+25.26%155.70M
-62.89%30.60M
-69.03%33.30M
-19.98%93.60M
-19.83%124.30M
-24.92%82.45M
-4.68%107.53M
+39.83%116.97M
+36.74%155.05M
+2.84%109.81M
-5.20%112.80M
-5.02%83.65M
+18.75%113.39M
Profit from Continuing Operations
+25.51%171.70M
+7.04%199.10M
+42.46%122.80M
-11.37%138.00M
+347.06%136.80M
+458.56%186.00M
-7.90%86.20M
+25.26%155.70M
-62.89%30.60M
-69.03%33.30M
-19.98%93.60M
-19.83%124.30M
-24.92%82.45M
-4.68%107.53M
+39.83%116.97M
+36.74%155.05M
+2.84%109.81M
-5.20%112.80M
-5.02%83.65M
+18.75%113.39M
Minority Interests
----
----
--0.00
--0.00
--0.00
--0.00
+100.00%0.00
+100.00%0.00
-100.00%0.00
-100.00%0.00
+42.75%-463.39K
-796.50%-936.61K
-0.09%1.07M
+142.48%2.28M
-200.95%-809.45K
-0.02%134.47K
--1.08M
--941.15K
-318778.61%-268.96K
--134.50K
Net Income to Parent Company
+25.51%171.70M
+7.04%199.10M
+42.46%122.80M
-11.37%138.00M
+347.06%136.80M
+458.56%186.00M
-8.36%86.20M
+24.32%155.70M
-62.40%30.60M
-68.36%33.30M
-20.14%94.06M
-19.16%125.24M
-25.16%81.37M
-5.92%105.25M
+40.35%117.78M
+36.79%154.91M
+1.83%108.73M
-5.99%111.86M
-4.71%83.92M
+18.61%113.25M
Other Preferred Stock Dividends
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Net Income to Common Stockholders
+25.51%171.70M
+7.04%199.10M
+42.46%122.80M
-11.37%138.00M
+347.06%136.80M
+458.56%186.00M
-8.36%86.20M
+24.32%155.70M
-62.40%30.60M
-68.36%33.30M
-20.14%94.06M
-19.16%125.24M
-25.16%81.37M
-5.92%105.25M
+40.35%117.78M
+36.79%154.91M
+1.83%108.73M
-5.99%111.86M
-4.71%83.92M
+18.61%113.25M
Basic EPS
+27.59%0.37
+7.50%0.43
+36.84%0.26
-11.76%0.30
+383.33%0.29
+400.00%0.40
-45.36%0.19
-24.82%0.34
-79.60%0.06
-78.94%0.08
-18.53%0.35
-19.35%0.45
-25.07%0.29
-5.81%0.38
+40.66%0.43
+37.14%0.56
+2.40%0.39
-5.36%0.40
-3.70%0.30
+19.87%0.41
Diluted EPS
+27.59%0.37
+7.50%0.43
+36.84%0.26
-11.76%0.30
+383.33%0.29
+400.00%0.40
-43.97%0.19
-24.60%0.34
-79.50%0.06
-78.87%0.08
-20.06%0.34
-19.01%0.45
-24.90%0.29
-5.52%0.38
+41.03%0.42
+37.51%0.56
+2.42%0.39
-5.40%0.40
-4.14%0.30
+19.15%0.40
Dividend Per Share
--0.00
+1.06%0.57
--0.00
+12.16%0.30
-100.00%0.00
--0.56
-100.00%0.00
--0.27
--0.27
-100.00%0.00
--0.56
--0.00
--0.00
+9.01%0.81
--0.00
--0.00
--0.00
+4.76%0.74
--0.00
--0.00
Deadline
Jun 30, 2026
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Accounting Standard
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
2026/Q22026/Q12025/Q42025/Q32025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q12021/Q42021/Q3
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla Show More